Stock Watch: Some Turbulence As Novo And Lilly Report Results
Investors Should Value Birds In The Hand Above Fledglings In The Bush
Novo disappointed on high expectations with its second-quarter announcement resulting in stock price weakness. But after Lilly reported without disappointment, something unexpected happened.
